Tue, October 1, 2024
[ 12:00 AM ] - WOPRAI
Fri, September 27, 2024
[ 12:00 AM ] - WOPRAI
Tue, September 24, 2024
Fri, September 20, 2024
[ 12:00 AM ] - WOPRAI
Tue, September 17, 2024
[ 12:00 AM ] - WOPRAI
Mon, September 16, 2024
[ 12:00 AM ] - WOPRAI
Fri, September 6, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, September 3, 2024
[ 12:00 AM ] - WOPRAI
Mon, August 19, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 16, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 15, 2024
[ 12:00 AM ] - WOPRAI
Wed, August 14, 2024
[ 12:00 AM ] - WOPRAI
Mon, August 12, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, August 8, 2024
[ 12:00 AM ] - WOPRAI
Mon, August 5, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, July 18, 2024
[ 12:00 AM ] - WOPRAI
Wed, July 10, 2024
[ 12:00 AM ] - WOPRAI
Tue, July 2, 2024
[ 12:00 AM ] - WOPRAI
Tue, June 25, 2024
[ 12:00 AM ] - WOPRAI
Thu, June 20, 2024
Thu, June 13, 2024
Tue, June 11, 2024
[ 12:00 AM ] - WOPRAI
Fri, June 7, 2024
[ 12:00 AM ] - WOPRAI
Thu, June 6, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 29, 2024
Ed Arce Reiterated (ARCT) at Strong Buy and Held Target at $63 on, Oct 1st, 2024
Ed Arce of HC Wainwright & Co., Reiterated "Arcturus Therapeutics Holdings Inc." (ARCT) at Strong Buy and Held Target at $63 on, Oct 1st, 2024.
Ed has made no other calls on ARCT in the last 4 months.
There are 3 other peers that have a rating on ARCT. Out of the 3 peers that are also analyzing ARCT, 0 agree with Ed's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Ed
- Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy on, Monday, September 9th, 2024
- Lili Nsongo of "Leerink Partners" Initiated at Buy and Held Target at $70 on, Monday, August 12th, 2024
- Pete Stavropoulos of "Cantor Fitzgerald" Reiterated at Buy on, Tuesday, August 6th, 2024
Contributing Sources